Navigation Links
Amnis Announces Record 2009 Sales
Date:2/11/2010

SEATTLE, Feb. 11 /PRNewswire/ -- Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced record 2009 sales results. The successful launch of the ImageStreamX imaging flow cytometer resulted in annual sales growth in excess of 75% and the company's first cash flow positive quarter.  Strong early sales for the new instrument consumed the company's manufacturing capacity for 2009 and well into 2010.

"We designed the new ImageStreamX platform to be ten times faster and much more powerful than the product it replaces while lowering the price by nearly a third. Given this tremendous value proposition, we expected an uptick in sales but our expectations were tempered by the difficult economic conditions throughout 2009," said David Basiji, Ph.D., Amnis' President and Chief Executive Officer. Basiji added, "Needless to say, we're thrilled with 75% sales growth in 2009 and we continue to see strong demand in early 2010."

"We've crossed the cash flow break even point and we're looking at full year profitability in 2010," remarked William Ortyn, Amnis' co-founder and Chief Operating Officer.  "The ImageStreamX has crossed several performance thresholds opening new market segments for Amnis," added Ortyn.

About Amnis: Amnis Corporation, headquartered in Seattle, WA, develops, manufactures and markets instrumentation for high speed cell imaging for research and diagnostic markets. The ImageStream system, introduced in 2005, is in service in over 15 countries world-wide. Researchers have utilized ImageStream technology to produce over 100 groundbreaking scientific publications. (www.amnis.com)

SOURCE Amnis Corporation

RELATED LINKS
http://www.amnis.com

'/>"/>

SOURCE Amnis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Amnis to Present at the 28th Annual J.P. Morgan Healthcare Conference
2. Amnis Begins Shipment of New ImageStreamX Imaging Flow Cytometers
3. Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010
4. The American Academy of Pain Medicine Announces this Years Presidential Commendations and Awards
5. CORD:USE Cord Blood Bank Announces Partnership with Memorial Healthcare System
6. Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma
7. Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
8. Kensey Nash Announces $30 Million Share Buyback
9. Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators
10. ISTA Pharmaceuticals Announces 2010 Financial Guidance
11. Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... ... On Saturday, October 21, the Health & Wellness Center at Florida Hospital ... for the American Heart Association Heart Walk. Teams of up to 10 people can ... their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. on Saturday, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer Dr. ... colleagues, skilled nursing facility medical directors and other clinicians at various events in ... , "At many of these conferences we get to educate other physicians, facility ...
Breaking Medicine News(10 mins):